Skip to main content
Clinical Trials/CTRI/2022/03/041263
CTRI/2022/03/041263Not yet recruitingPhase 2

Efficacy of Agnikarma and Varadi Guggulu in management of Garbhashaya Mukhagata Vrana(Cervical erosion) : Single arm Clinical Trial

Institute of Teaching and Research in AyurvedaJamnagar0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Married women of 21-60 years age group.
  • 2.Patients presenting the signs and symptoms like white discharge/abnormal vaginal discharge, contact bleeding, backache, O/E presence of cervical erosion with cervicitis/ endocervicitis/ hypertrophy, unhealthy cervix, nabothian cyst or only presence of cervical erosion
  • 3.Pap smear confirming: acute cervicitis/chronic cervicitis or both or CIN I. (As per Bethesda classification)
  • 4.Suitable for Agnikarma

Exclusion Criteria

  • 1.Unmarried women.
  • 2.Women below 21 years and above 60 years.
  • 3.Pregnant women & those who are taking OC pills.
  • 4.Diagnosed patients with following condition -
  • Tuberculosis and carcinoma of genital tracts
  • CIN Grade II & III (As per Bethesda classification)
  • Procidentia
  • 5.Patients suffering from diseases like STDs, AIDS, etc.
  • 6.Patients with uncontrolled DM (RBS > 200 mg/dl), HTN (160/100 mm Hg),
  • 7.Unsuitable for Agnikarma

Investigators

Sponsor
Institute of Teaching and Research in AyurvedaJamnagar

Similar Trials